SCA Pharmaceuticals makes sterile admixtures and pre-filled syringes for hospital pharmacies under FDA 503B compounding.
Founded in 2010 in Little Rock, US, SCA Pharmaceuticals, LLC provides sterile compounding under the FDA 503B outsourcing framework, supplying admixtures and pre-filled syringes to hospitals in critical care, labor and delivery, anesthesia and pain management. It is licensed in all 50 states and sells mainly through multi-year supply contracts. Excellere Partners and The Vistria Group acquired the company in January 2021 for USD 125 mn. CEO Scott Luce leads it.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in